@article{ref1,
title="Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study",
journal="Psychiatry and the Clinical Neurosciences",
year="2019",
author="Takaesu, Yoshikazu and Watanabe, Koichiro and Numata, Shusuke and Iwata, Masaaki and Kudo, Noriko and Oishi, Satoru and Takizawa, Takeya and Nemoto, Kiyotaka and Yasuda, Yuka and Tagata, Hiromi and Tsuboi, Takashi and Tsujino, Naohisa and Hashimoto, Naoki and Matsui, Yuki and Hori, Hikaru and Yamamori, Hidenaga and Sugiyama, Nobuhiro and Suwa, Taro and Kishimoto, Taishiro and Hishimoto, Akitoyo and Usami, Masahide and Furihata, Ryuji and Iwamoto, Kunihiro and Fujishiro, Hiroshige and Nakamura, Toshinori and Mizuno, Kentaro and Inagaki, Takahiko and Katsumoto, Eiichi and Tomita, Hiroaki and Ohi, Kazutaka and Muraoka, Hiroyuki and Atake, Kiyokazu and Iida, Hitoshi and Nagasawa, Tatsuya and Fujita, Junichi and Yamamura, Satoshi and Onitsuka, Toshiaki and Murata, Atsunobu and Takayanagi, Yoichiro and Noda, Hokuto and Matsumura, Yukiko and Takezawa, Kenji and Iga, Jun-Ichi and Ichihashi, Kayo and Ogasawara, Kazuyoshi and Yamada, Hisashi and Inada, Ken and Hashimoto, Ryota",
volume="ePub",
number="ePub",
pages="ePub-ePub",
abstract="AIM: Although treatment guidelines for pharmacological therapy for schizophrenia and major depressive disorder have been issued by the Japanese Societies of Neuropsychopharmacology and Mood Disorders, these guidelines have not been well applied by psychiatrists throughout the nation. To address this issue, we developed the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' integrated education programs for psychiatrists to disseminate the clinical guidelines. Additionally, we conducted a systematic efficacy evaluation of the programs. <br><br>METHODS: Four hundred thirteen out of 461 psychiatrists attended two 1-day educational programs based on the treatment guidelines for schizophrenia and major depressive disorder from October 2016 to March 2018. We measured the participants' clinical knowledge of the treatment guidelines using self-completed questionnaires administered before and after the program to assess the effectiveness of the programs for improving knowledge. We also examined the relation between the participants' demographics and their clinical knowledge scores. <br><br>RESULTS: The clinical knowledge scores for both guidelines were significantly improved after the program. There was no correlation between clinical knowledge and participant demographics for the program on schizophrenia; however, a weak positive correlation was found between clinical knowledge and the years of professional experience for the program on major depressive disorder. <br><br>CONCLUSION: Our results provide evidence that educational programs on the clinical practices recommended in guidelines for schizophrenia and major depressive disorder might effectively improve participants' clinical knowledge of the guidelines. These data are encouraging to facilitate the standardization of clinical practices for psychiatric disorders.<br><br>© 2019 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.<p /> <p>Language: en</p>",
language="en",
issn="1323-1316",
doi="10.1111/pcn.12911",
url="http://dx.doi.org/10.1111/pcn.12911"
}